Vaccine Research and Development
The vaccine called “ROTAVAC” for rotaviral diarrhea was successfully developed as the first indigenous vaccine from an Indian strain (116E) by Indian investigators and manufactured by an Indian company with the support of Government and global partners. The development of other vaccines such as Dengue, Malaria, Cholera, HIV, HPV, JE, Tuberculosis etc. are in advanced stages of clinical evaluation.
This information was given by Minister of Science and Technology Dr. Harsh Vardhan in Lok Sabha today.
Related Press Releases
- DBT Announces Phase III Clinical Trial Results of Rotavirus Vaccine Developed in India Say Vaccine Demonstrates Strong Efficacy
- First Indigenous Rotavirus Vaccine and also an Injectable Polio Vaccine Developed with the DBT and Launched Formallty has been made available to the Union Ministry of Health –Dr Jitendra Singh
- THREE NEW VACCINES INCLUDING INDIGENOUSLY DEVELOPED ROTAVIRUS VACCINE TO BE PROVIDED TO ALL INDIAN CHILDREN Fourth vaccine for adults to protect against Japanese Encephalitis to be introduced in high-
- Memorandum of Understanding Signed Between Central Pulp & Paper Research Institute (CPPRI) and Security Printing and Minting Corporation of India Ltd (SPMCIL) for Undertaking Research and Development
- Expenditure on Research and Development
- Dr. Shripad Yesso Naik gives away awards to the winners of the Hindi Pakhwada Calls Hindi our ‘Samparkbhasa’
- STUDENTS FROM FERGUSSON COLLEGE, PUNE CALL ON VICE PRESIDENT
Search for PIB News
The contents of this website is sourced from press releases issued by the Press Information Bureau, Govt. of India. The official PIB website is at www.pib.nic.in